Microbiology is the study of the bacteria, fungi, viruses and parasites that invade the body. Medical Microbiology includes diagnostic microbiology, infection prevention and control, clinical infectious diseases, and antimicrobial stewardship.
All Health PEI guidelines and tools are also available on Firstline app.
Please download by visiting: https://firstline.org/health-pei/
PEI Antimicrobial Treatment Guidelines (Adults):
- Acute Exacerbation of Chronic Obstructive Pulmonary Disease (COPD) (2021) [PDF]
- Clostridioides (Clostridium) difficile Infection (2023) [PDF]
- Diabetic Foot Infections (2023) [PDF]
- Gram Positive Cocci in Clusters Bacteremia (2016) [PDF]
- Lyme Disease Algorithm (2023) [PDF]
- Sepsis Syndromes
- Skin and Soft Tissue Infections (2023) [PDF]
- Urinary Tract Infection (2018) [PDF]
Respiratory:
- Adult Chemical Pneumonitis and Aspiration Pneumonia (2024) [PDF]
- Community Acquired Pneumonia (2024) [PDF]
- Hospital Acquired Pneumonia (2024) [PDF]
- Ventilator Associated Pneumonia (2024) [PDF]
Useful Tools:
- Antibiogram 2024 PDF
- IV to PO Antimicrobial Step-down Guidelines (2020) [PDF]
- Virus Plan (October 2017) [PDF]
- Duration of Therapy Guideline - Antimicrobials [PDF]
Beta-Lactam Allergy Management:
- Beta-Lactam Cross Allergy Matrix (2017) [PDF]
- Penicillin Allergy Management Algorithm (2017) [PDF]
- Management of Penicillin and Beta-Lactam Allergy Guidelines (2017) [PDF]
Please see the “Memos” section below for: Management of Beta-Lactam Allergies Bulletin, Beta-Lactam Allergy Management and PEI Provincial Guidelines Presentation, and Beta-lactam Cross Reaction Allergy Alert Modifications memo.
Malaria:
- Canadian Malaria Network Standard Operating Procedure (Version 1) [PDF]
- CMN Complete Malaria Package [PDF]
Scabies:
- 2018-08-31 | Memo from the Chief Public Health Office: Scabies identification and treatment [PDF]
- Scabies Fact Sheet (Chief Public Health Office) [PDF]
Zika Virus:
Requisitions:
- See the Laboratory Requisitions page
Analysis:
- PEI Laboratory Surveillance of Viral Respiratory Infections
- Clostridium difficile Risk with Specific Anti-infectives or Anti-infective Classes [PDF]
Memos:
- 2024-10-09 | Empiric Antimicrobial Management of Pneumonia [PDF]
- 2024-05-23 | Respiratory Screen (Covid 19/Flu A/B+RSV) Testing; Respiratory Panel Criteria (end of respiratory season) PDF
- 2024-02-26 Health PEI Antibiogram 2024: Highlight of Practice Points PDF
- 2023-08-02 | IV Amoxicillin/Clavulanate Now Available in Hospital PDF
- 2023-03-07 | New Collection and Order for Chlamydia Trachomatis, Neisseria Gonorrhea & Trichomonas Vaginalis
- 2021-07-08 | Pneumococcal 7 Testing [PDF]
- 2021-03-15 | Diagnosing and Treating Bone Infections [PDF]
- 2018-06-18 | Acceptable specimens for fungal culture [PDF]
- 2020-01-16 | Beta-lactam Cross Reaction Allergy Alert Modifications [PDF]
- 2019-07-30 | Updated Clostridioides (Clostridium) difficile Infection Treatment Guidelines in Adults [PDF]
- 2018-05-02 | Kefir Ordering [PDF]
- 2017-11-14 | Management of Beta-Lactam Allergies Bulletin (November 2017) [PDF]
- 2017-11-14 | Beta-Lactam Allergy Management and PEI Provincial Guidelines Presentation (November 2017) [PDF]
- 2014-09-15 | Linezolid and Daptomycin Formulary Restrictions [PDF]
- 2014-09-04 | Sepsis Management PowerPlan [PDF]
Quality Indicators:
- Blood Culture Utilization and Quality 2021 - 2023 [PDF]
- Blood Culture Utilization and Quality 2020-2022 [PDF]
- Blood Culture Utilization and Quality 2019-2021 [PDF]
- Blood Culture Utilization and Quality 2018-2020 [PDF]
- Blood Culture Utilization and Quality 2015-2017 [PDF]
For questions please contact Fiona Mitchell (Provincial Antimicrobial Stewardship Pharmacist; 902-894-2587; fcmitchell@ihis.org).